Osprey reported its twelfth consecutive quarter of unit sales growth for its dye saving technologies. DyeVert and DyeVert Plus unit sales grew by 8% to 1,241 units in 3Q 2017, compared to 1,149 units sold in 2Q 2017. This represents growth of 178% compared with 3Q 2016. Sales reached US$441k in 3Q 2017 up 183% vs 3Q 2016 (US$156k).
Unit sales growth was materially impacted by Hurricanes Harvey and Irma, which caused widespread disruption across a number of highly populated areas in the southern United States. In many of the hurricane-affected areas, routine hospital procedures were postponed or cancelled over a period of several weeks, resulting in a temporary fall in demand for Osprey’s products.
In recent quarters, Osprey’s sales territories in the affected areas of South Texas, Florida and Georgia have generated two-thirds of Osprey’s unit sales. The exceptional impact of the hurricanes led to a decline in unit sales in these territories compared with the second quarter 2017. Continued strong growth in the unaffected territories enabled Osprey to record a modest growth rate for the business as a whole.
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.